Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 194

1.

Information processing speed in multiple sclerosis: Relevance of default mode network dynamics.

van Geest Q, Douw L, van 't Klooster S, Leurs CE, Genova HM, Wylie GR, Steenwijk MD, Killestein J, Geurts JJG, Hulst HE.

Neuroimage Clin. 2018 May 15;19:507-515. doi: 10.1016/j.nicl.2018.05.015. eCollection 2018.

2.

Urgent challenges in quantification and interpretation of brain grey matter atrophy in individual MS patients using MRI.

Amiri H, de Sitter A, Bendfeldt K, Battaglini M, Gandini Wheeler-Kingshott CAM, Calabrese M, Geurts JJG, Rocca MA, Sastre-Garriga J, Enzinger C, de Stefano N, Filippi M, Rovira Á, Barkhof F, Vrenken H; MAGNIMS Study Group.

Neuroimage Clin. 2018 Apr 26;19:466-475. doi: 10.1016/j.nicl.2018.04.023. eCollection 2018. Review.

3.

Thinking about the nerve impulse: A critical analysis of the electricity-centered conception of nerve excitability.

Drukarch B, Holland HA, Velichkov M, Geurts JJG, Voorn P, Glas G, de Regt HW.

Prog Neurobiol. 2018 Jul 4. pii: S0301-0082(18)30050-9. doi: 10.1016/j.pneurobio.2018.06.009. [Epub ahead of print] Review.

4.

Determinants of Cognitive Impairment in Patients with Multiple Sclerosis with and without Atrophy.

Eijlers AJC, Meijer KA, van Geest Q, Geurts JJG, Schoonheim MM.

Radiology. 2018 May 18:172808. doi: 10.1148/radiol.2018172808. [Epub ahead of print]

PMID:
29786489
5.

The importance of hippocampal dynamic connectivity in explaining memory function in multiple sclerosis.

van Geest Q, Hulst HE, Meijer KA, Hoyng L, Geurts JJG, Douw L.

Brain Behav. 2018 Mar 30;8(5):e00954. doi: 10.1002/brb3.954. eCollection 2018 May.

6.

Progression of regional grey matter atrophy in multiple sclerosis.

Eshaghi A, Marinescu RV, Young AL, Firth NC, Prados F, Jorge Cardoso M, Tur C, De Angelis F, Cawley N, Brownlee WJ, De Stefano N, Laura Stromillo M, Battaglini M, Ruggieri S, Gasperini C, Filippi M, Rocca MA, Rovira A, Sastre-Garriga J, Geurts JJG, Vrenken H, Wottschel V, Leurs CE, Uitdehaag B, Pirpamer L, Enzinger C, Ourselin S, Gandini Wheeler-Kingshott CA, Chard D, Thompson AJ, Barkhof F, Alexander DC, Ciccarelli O.

Brain. 2018 Jun 1;141(6):1665-1677. doi: 10.1093/brain/awy088.

7.

A discrete polar Stockwell transform for enhanced characterization of tissue structure using MRI.

Pridham G, Steenwijk MD, Geurts JJG, Zhang Y.

Magn Reson Med. 2018 May 2. doi: 10.1002/mrm.27219. [Epub ahead of print]

PMID:
29722063
8.

Lipid biochemical changes detected in normal appearing white matter of chronic multiple sclerosis by spectral coherent Raman imaging.

Poon KWC, Brideau C, Klaver R, Schenk GJ, Geurts JJ, Stys PK.

Chem Sci. 2018 Jan 2;9(6):1586-1595. doi: 10.1039/c7sc03992a. eCollection 2018 Feb 14.

9.

Fronto-limbic disconnection in patients with multiple sclerosis and depression.

van Geest Q, Boeschoten RE, Keijzer MJ, Steenwijk MD, Pouwels PJ, Twisk JW, Smit JH, Uitdehaag BM, Geurts JJ, van Oppen P, Hulst HE.

Mult Scler. 2018 Mar 1:1352458518767051. doi: 10.1177/1352458518767051. [Epub ahead of print]

PMID:
29587565
10.

Postmortem magnetic resonance imaging.

Jonkman LE, Geurts JJG.

Handb Clin Neurol. 2018;150:335-354. doi: 10.1016/B978-0-444-63639-3.00023-2.

PMID:
29496152
11.

Explaining the heterogeneity of functional connectivity findings in multiple sclerosis: An empirically informed modeling study.

Tewarie P, Steenwijk MD, Brookes MJ, Uitdehaag BMJ, Geurts JJG, Stam CJ, Schoonheim MM.

Hum Brain Mapp. 2018 Jun;39(6):2541-2548. doi: 10.1002/hbm.24020. Epub 2018 Feb 21.

12.

Cognition in multiple sclerosis: State of the field and priorities for the future.

Sumowski JF, Benedict R, Enzinger C, Filippi M, Geurts JJ, Hamalainen P, Hulst H, Inglese M, Leavitt VM, Rocca MA, Rosti-Otajarvi EM, Rao S.

Neurology. 2018 Feb 6;90(6):278-288. doi: 10.1212/WNL.0000000000004977. Epub 2018 Jan 17. Review.

13.

Neuropsychology of Multiple Sclerosis: Looking Back and Moving Forward.

Benedict RHB, DeLuca J, Enzinger C, Geurts JJG, Krupp LB, Rao SM.

J Int Neuropsychol Soc. 2017 Oct;23(9-10):832-842. doi: 10.1017/S1355617717000959. Review.

PMID:
29198279
14.

9.4T and 17.6T MRI of Retinoblastoma: Ex Vivo evaluation of microstructural anatomy and disease extent compared with histopathology.

de Jong MC, de Graaf P, Pouwels PJW, Beenakker JW, Jansen RW, Geurts JJG, Moll AC, Castelijns JA, van der Valk P, van der Weerd L.

J Magn Reson Imaging. 2018 Jun;47(6):1487-1497. doi: 10.1002/jmri.25913. Epub 2017 Nov 28.

PMID:
29193569
15.

Cognitive rehabilitation and mindfulness in multiple sclerosis (REMIND-MS): a study protocol for a randomised controlled trial.

Nauta IM, Speckens AEM, Kessels RPC, Geurts JJG, de Groot V, Uitdehaag BMJ, Fasotti L, de Jong BA.

BMC Neurol. 2017 Nov 21;17(1):201. doi: 10.1186/s12883-017-0979-y.

16.

Asymptomatic spinal cord lesions do not predict the time to disability in patients with early multiple sclerosis.

Dekker I, Sombekke MH, Witte BI, Geurts JJ, Barkhof F, Uitdehaag BM, Killestein J, Wattjes MP.

Mult Scler. 2018 Apr;24(4):481-490. doi: 10.1177/1352458517736147. Epub 2017 Nov 6.

17.

Staging of cortical and deep grey matter functional connectivity changes in multiple sclerosis.

Meijer KA, Eijlers AJC, Geurts JJG, Schoonheim MM.

J Neurol Neurosurg Psychiatry. 2018 Feb;89(2):205-210. doi: 10.1136/jnnp-2017-316329. Epub 2017 Oct 6.

PMID:
28986469
18.

Cognitive impairment and the regional distribution of cerebellar lesions in multiple sclerosis.

Tobyne SM, Ochoa WB, Bireley JD, Smith VM, Geurts JJ, Schmahmann JD, Klawiter EC.

Mult Scler. 2017 Sep 1:1352458517730132. doi: 10.1177/1352458517730132. [Epub ahead of print]

PMID:
28933672
19.

Cortical pathology in multiple sclerosis detected by the T1/T2-weighted ratio from routine magnetic resonance imaging.

Righart R, Biberacher V, Jonkman LE, Klaver R, Schmidt P, Buck D, Berthele A, Kirschke JS, Zimmer C, Hemmer B, Geurts JJG, Mühlau M.

Ann Neurol. 2017 Oct;82(4):519-529. doi: 10.1002/ana.25020. Epub 2017 Sep 16.

20.

Cortical Remyelination Is Heterogeneous in Multiple Sclerosis.

Strijbis EMM, Kooi EJ, van der Valk P, Geurts JJG.

J Neuropathol Exp Neurol. 2017 May 1;76(5):390-401. doi: 10.1093/jnen/nlx023.

PMID:
28521040
21.

Increased connectivity of hub networks and cognitive impairment in multiple sclerosis.

Meijer KA, Eijlers AJC, Douw L, Uitdehaag BMJ, Barkhof F, Geurts JJG, Schoonheim MM.

Neurology. 2017 May 30;88(22):2107-2114. doi: 10.1212/WNL.0000000000003982. Epub 2017 May 3.

PMID:
28468841
22.

Metabolites predict lesion formation and severity in relapsing-remitting multiple sclerosis.

Klauser AM, Wiebenga OT, Eijlers AJ, Schoonheim MM, Uitdehaag BM, Barkhof F, Pouwels PJ, Geurts JJ.

Mult Scler. 2018 Apr;24(4):491-500. doi: 10.1177/1352458517702534. Epub 2017 Apr 13.

PMID:
28406063
23.

The measure tells the tale: Clinical outcome measures in multiple sclerosis.

Hulst HE, Thompson AJ, Geurts JJ.

Mult Scler. 2017 Apr;23(5):626-627. doi: 10.1177/1352458517690825. Epub 2017 Feb 16. No abstract available.

PMID:
28206813
24.

Increased default-mode network centrality in cognitively impaired multiple sclerosis patients.

Eijlers AJ, Meijer KA, Wassenaar TM, Steenwijk MD, Uitdehaag BM, Barkhof F, Wink AM, Geurts JJ, Schoonheim MM.

Neurology. 2017 Mar 7;88(10):952-960. doi: 10.1212/WNL.0000000000003689. Epub 2017 Feb 8.

PMID:
28179464
25.

Dynamic hub load predicts cognitive decline after resective neurosurgery.

Carbo EW, Hillebrand A, van Dellen E, Tewarie P, de Witt Hamer PC, Baayen JC, Klein M, Geurts JJ, Reijneveld JC, Stam CJ, Douw L.

Sci Rep. 2017 Feb 7;7:42117. doi: 10.1038/srep42117.

26.

Connectomic profile and clinical phenotype in newly diagnosed glioma patients.

Derks J, Dirkson AR, de Witt Hamer PC, van Geest Q, Hulst HE, Barkhof F, Pouwels PJ, Geurts JJ, Reijneveld JC, Douw L.

Neuroimage Clin. 2017 Jan 16;14:87-96. doi: 10.1016/j.nicl.2017.01.007. eCollection 2017.

27.

Brain MRI atrophy quantification in MS: From methods to clinical application.

Rocca MA, Battaglini M, Benedict RH, De Stefano N, Geurts JJ, Henry RG, Horsfield MA, Jenkinson M, Pagani E, Filippi M.

Neurology. 2017 Jan 24;88(4):403-413. doi: 10.1212/WNL.0000000000003542. Epub 2016 Dec 16. Review.

28.

rTMS affects working memory performance, brain activation and functional connectivity in patients with multiple sclerosis.

Hulst HE, Goldschmidt T, Nitsche MA, de Wit SJ, van den Heuvel OA, Barkhof F, Paulus W, van der Werf YD, Geurts JJG.

J Neurol Neurosurg Psychiatry. 2017 May;88(5):386-394. doi: 10.1136/jnnp-2016-314224. Epub 2016 Dec 14.

PMID:
27974394
29.

Complement C3 on microglial clusters in multiple sclerosis occur in chronic but not acute disease: Implication for disease pathogenesis.

Michailidou I, Naessens DM, Hametner S, Guldenaar W, Kooi EJ, Geurts JJ, Baas F, Lassmann H, Ramaglia V.

Glia. 2017 Feb;65(2):264-277. doi: 10.1002/glia.23090. Epub 2016 Oct 25.

30.

The role of sleep on cognition and functional connectivity in patients with multiple sclerosis.

van Geest Q, Westerik B, van der Werf YD, Geurts JJ, Hulst HE.

J Neurol. 2017 Jan;264(1):72-80. doi: 10.1007/s00415-016-8318-6. Epub 2016 Oct 24.

31.

Visualization of cortical MS lesions with MRI need not be further improved - YES.

Geurts JJ, Chard DT.

Mult Scler. 2017 Jan;23(1):15-17. doi: 10.1177/1352458516665498. Epub 2016 Sep 28. No abstract available.

PMID:
27566450
32.

Patterns of white matter damage are non-random and associated with cognitive function in secondary progressive multiple sclerosis.

Meijer KA, Cercignani M, Muhlert N, Sethi V, Chard D, Geurts JJ, Ciccarelli O.

Neuroimage Clin. 2016 Jun 14;12:123-31. doi: 10.1016/j.nicl.2016.06.009. eCollection 2016.

33.

Demyelination induces transport of ribosome-containing vesicles from glia to axons: evidence from animal models and MS patient brains.

Shakhbazau A, Schenk GJ, Hay C, Kawasoe J, Klaver R, Yong VW, Geurts JJ, van Minnen J.

Mol Biol Rep. 2016 Jun;43(6):495-507. doi: 10.1007/s11033-016-3990-2. Epub 2016 Apr 26.

PMID:
27115494
34.

White Matter Diffusion Changes during the First Year of Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis.

Wiebenga OT, Schoonheim MM, Hulst HE, Nagtegaal GJ, Strijbis EM, Steenwijk MD, Polman CH, Pouwels PJ, Barkhof F, Geurts JJ.

AJNR Am J Neuroradiol. 2016 Jun;37(6):1030-7. doi: 10.3174/ajnr.A4690. Epub 2016 Mar 10.

35.

Increased cortical grey matter lesion detection in multiple sclerosis with 7 T MRI: a post-mortem verification study.

Kilsdonk ID, Jonkman LE, Klaver R, van Veluw SJ, Zwanenburg JJ, Kuijer JP, Pouwels PJ, Twisk JW, Wattjes MP, Luijten PR, Barkhof F, Geurts JJ.

Brain. 2016 May;139(Pt 5):1472-81. doi: 10.1093/brain/aww037. Epub 2016 Mar 8.

PMID:
26956422
36.

Postmortem validation of MRI cortical volume measurements in MS.

Popescu V, Klaver R, Versteeg A, Voorn P, Twisk JW, Barkhof F, Geurts JJ, Vrenken H.

Hum Brain Mapp. 2016 Jun;37(6):2223-33. doi: 10.1002/hbm.23168. Epub 2016 Mar 4.

PMID:
26945922
37.

The substrate of increased cortical FA in MS: A 7T post-mortem MRI and histopathology study.

Jonkman LE, Klaver R, Fleysher L, Inglese M, Geurts JJ.

Mult Scler. 2016 Dec;22(14):1804-1811. Epub 2016 Mar 4.

PMID:
26945031
38.

Multi-scale MRI spectrum detects differences in myelin integrity between MS lesion types.

Zhang Y, Jonkman L, Klauser A, Barkhof F, Yong VW, Metz LM, Geurts JJ.

Mult Scler. 2016 Oct;22(12):1569-1577. Epub 2016 Jan 11.

PMID:
26754802
39.

White matter tract abnormalities are associated with cognitive dysfunction in secondary progressive multiple sclerosis.

Meijer KA, Muhlert N, Cercignani M, Sethi V, Ron MA, Thompson AJ, Miller DH, Chard D, Geurts JJ, Ciccarelli O.

Mult Scler. 2016 Oct;22(11):1429-1437. Epub 2016 Jan 5.

PMID:
26733423
40.

Ultra-high field MTR and qR2* differentiates subpial cortical lesions from normal-appearing gray matter in multiple sclerosis.

Jonkman LE, Fleysher L, Steenwijk MD, Koeleman JA, de Snoo TP, Barkhof F, Inglese M, Geurts JJ.

Mult Scler. 2016 Sep;22(10):1306-14. doi: 10.1177/1352458515620499. Epub 2015 Dec 16.

PMID:
26672996
41.

Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant.

Steenwijk MD, Geurts JJ, Daams M, Tijms BM, Wink AM, Balk LJ, Tewarie PK, Uitdehaag BM, Barkhof F, Vrenken H, Pouwels PJ.

Brain. 2016 Jan;139(Pt 1):115-26. doi: 10.1093/brain/awv337. Epub 2015 Dec 4.

PMID:
26637488
42.

High-resolution T1-relaxation time mapping displays subtle, clinically relevant, gray matter damage in long-standing multiple sclerosis.

Steenwijk MD, Vrenken H, Jonkman LE, Daams M, Geurts JJ, Barkhof F, Pouwels PJ.

Mult Scler. 2016 Sep;22(10):1279-88. doi: 10.1177/1352458515615953. Epub 2015 Nov 12.

PMID:
26564997
43.

Ultra-High-Field MRI Visualization of Cortical Multiple Sclerosis Lesions with T2 and T2*: A Postmortem MRI and Histopathology Study.

Jonkman LE, Klaver R, Fleysher L, Inglese M, Geurts JJ.

AJNR Am J Neuroradiol. 2015 Nov;36(11):2062-7. doi: 10.3174/ajnr.A4418. Epub 2015 Jul 30.

44.

Multi-parametric structural magnetic resonance imaging in relation to cognitive dysfunction in long-standing multiple sclerosis.

Daams M, Steenwijk MD, Schoonheim MM, Wattjes MP, Balk LJ, Tewarie PK, Killestein J, Uitdehaag BM, Geurts JJ, Barkhof F.

Mult Scler. 2016 Apr;22(5):608-19. doi: 10.1177/1352458515596598. Epub 2015 Jul 24.

PMID:
26209593
45.

Gray matter damage in multiple sclerosis: Impact on clinical symptoms.

van Munster CE, Jonkman LE, Weinstein HC, Uitdehaag BM, Geurts JJ.

Neuroscience. 2015 Sep 10;303:446-61. doi: 10.1016/j.neuroscience.2015.07.006. Epub 2015 Jul 8. Review.

PMID:
26164500
46.

Unraveling the neuroimaging predictors for motor dysfunction in long-standing multiple sclerosis.

Daams M, Steenwijk MD, Wattjes MP, Geurts JJ, Uitdehaag BM, Tewarie PK, Balk LJ, Pouwels PJ, Killestein J, Barkhof F.

Neurology. 2015 Jul 21;85(3):248-55. doi: 10.1212/WNL.0000000000001756. Epub 2015 Jun 26.

PMID:
26115736
47.

Clinico-Pathological Correlations of the Frontal Lobe Syndrome: Results of a Large Brain Bank Study.

Krudop WA, Bosman S, Geurts JJ, Sikkes SA, Verwey NA, Stek ML, Scheltens P, Rozemuller AJ, Pijnenburg YA.

Dement Geriatr Cogn Disord. 2015;40(3-4):121-9. doi: 10.1159/000430460. Epub 2015 Jun 12.

PMID:
26088035
48.

The primate autoimmune encephalomyelitis model; a bridge between mouse and man.

't Hart BA, van Kooyk Y, Geurts JJ, Gran B.

Ann Clin Transl Neurol. 2015 May;2(5):581-93. doi: 10.1002/acn3.194. Epub 2015 Mar 18. Review.

49.

Network collapse and cognitive impairment in multiple sclerosis.

Schoonheim MM, Meijer KA, Geurts JJ.

Front Neurol. 2015 Apr 14;6:82. doi: 10.3389/fneur.2015.00082. eCollection 2015. Review. No abstract available.

50.

DIR-visible grey matter lesions and atrophy in multiple sclerosis: partners in crime?

van de Pavert SH, Muhlert N, Sethi V, Wheeler-Kingshott CA, Ridgway GR, Geurts JJ, Ron M, Yousry TA, Thompson AJ, Miller DH, Chard DT, Ciccarelli O.

J Neurol Neurosurg Psychiatry. 2016 May;87(5):461-7. doi: 10.1136/jnnp-2014-310142. Epub 2015 Apr 29.

Supplemental Content

Loading ...
Support Center